Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated about 6 hours ago
Managing product data quality in PMS: processes, known issues, current status and best practices, Online, from 21 July 2026, 14:00 (CEST) to 21 July 2026, 15:30 (CEST)
about 7 hours ago
Managing product data quality in PMS: processes, known issues, current status and...
Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International), paliperidone, Date of authorisation: 18/06/2020, Revision: 5, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Byannli (previously Paliperidone Janssen-Cilag International)...
Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Oczyesa, octreotide, Date of authorisation...
Human medicines European public assessment report (EPAR): Vargatef, nintedanib, Date of authorisation: 21/11/2014, Revision: 22, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Vargatef, nintedanib, Date of authorisation...
Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation: 19/02/2018, Revision: 18, Status: Authorised
about 7 hours ago
Human medicines European public assessment report (EPAR): Crysvita, burosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 17, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 29, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation...
Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation: 20/09/2018, Revision: 15, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation...
Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of authorisation: 18/07/2022, Revision: 10, Status: Authorised
about 8 hours ago
Human medicines European public assessment report (EPAR): Upstaza, eladocagene exuparvovec, Date of...
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Status: Authorised
about 9 hours ago
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of...
List of eligible industry stakeholder organisations
about 9 hours ago
List of eligible industry stakeholder organisations
EMA/HMA European platform for regulatory science research platform meeting – draft agenda
about 12 hours ago
EMA/HMA European platform for regulatory science research platform meeting – draft agenda